An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease

This publication has 22 references indexed in Scilit:

• OM-85 BV for COPD
  American Journal of Respiratory and Critical Care Medicine, 1997
• The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma.
  American Journal of Respiratory and Critical Care Medicine, 1994
• Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.
  Thorax, 1993
• Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction.
  Thorax, 1993
• Reduction of budesonide after a year of increased use: A randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained
  Journal of Allergy and Clinical Immunology, 1991
• Effect of Long-term Treatment with an Inhaled Corticosteroid (Budesonide) on Airway Hyperresponsiveness and Clinical Asthma in Nonsteroid-dependent Asthmatics
  American Review of Respiratory Disease, 1990
• Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
  Thorax, 1990
• Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate.
  Thorax, 1990
• High Doses of Inhaled Corticosteroids in Unstable Chronic Asthma: A Multicenter, Double-blind, Placebo-controlled Study
  American Review of Respiratory Disease, 1989
• Corticosteroids in COPD
  Chest, 1986